Current Perspectives in Kidney Diseases. Группа авторов
17 Husi H, Sanchez-Niño MD, Delles C, Mullen W, Vlahou A, Ortiz A, et al: A combinatorial approach of proteomics and systems biology in unravelling the mechanisms of acute kidney injury (AKI): involvement of NMDA receptor GRIN1 in murine AKI. BMC Syst Biol 2013;7:110.
18 Gaarkeuken H, Siezenga MA, Zuidwijk K, van Kooten C, Rabelink TJ, Daha MR, et al: Complement activation by tubular cells is mediated by properdin binding. Am J Physiol Renal Physiol 2008;295:F1397–F1403.
19 Heng B, Li Y, Shi L, Du X, Lai C, Cheng L, et al: A meta-analysis of the significance of granzyme B and perforin in noninvasive diagnosis of acute rejection after kidney transplantation. Transplantation 2015;99:1477–1486.
20 Sun J, Shannon M, Ando Y, Schnackenberg LK, Khan NA, Portilla D, et al: Serum metabolomic profiles from patients with acute kidney injury: a pilot study. J Chromatogr B Analyt Technol Biomed Life Sci 2012;893–894:107–113.
21 Cantaluppi V, Medica D, Mannari C, Stiaccini G, Figliolini F, Dellepiane S, et al: Endothelial progenitor cell-derived extracellular vesicles protect from complement-mediated mesangial injury in experimental anti-Thy1.1 glomerulonephritis. Nephrol Dial Transplant 2015;30:410–422.
22 Zafrani L, Gerotziafas G, Byrnes C, Hu X, Perez J, Lévi C, et al: Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release. Am J Respir Crit Care Med 2012;185:744–755.
23 Meziani F, Delabranche X, Asfar P, Toti F: Bench-to-bedside review: circulating microparticles – a new player in sepsis? Crit Care 2010;14:236.
24 Mastronardi ML, Mostefai HA, Meziani F, Martínez MC, Asfar P, Andriantsitohaina R: Circulating microparticles from septic shock patients exert differential tissue expression of enzymes related to inflammation and oxidative stress. Crit Care Med 2011;39:1739–1748.
25 Legrand M, Dupuis C, Simon C, Gayat E, Mateo J, Lukaszewicz AC, et al: Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study. Crit Care 2013;17:R278.
26 Garzotto F, Ostermann M, Martín-Langerwerf D, Sánchez-Sánchez M, Teng J, Robert R, et al: The dose response multicentre investigation on fluid assessment (DoReMIFA) in critically ill patients. Crit Care 2016;20:196.
27 Lorente L, Martín MM, Varo N, Borreguero-León JM, Solé-Violán J, Blanquer J, et al: Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis. Crit Care 2011;15:R97.
28 Rimmelé T, Payen D, Cantaluppi V, Marshall J, Gomez H, Gomez A, et al: Immune cell phenotype and function in sepsis. Shock 2016;45:282–291.
29 Barbar SD, Binquet C, Monchi M, Bruyère R, Quenot JP: Impact on mortality of the timing of renal replacement therapy in patients with severe acute kidney injury in septic shock: the IDEAL-ICU study (initiation of dialysis early versus delayed in the intensive care unit): study protocol for a randomized controlled trial. Trials 2014;15:270.
30 Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, et al: Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2007;2:431–439.
31 Oppert M, Engel C, Brunkhorst FM, Bogatsch H, Reinhart K, Frei U, et al: Acute renal failure in patients with severe sepsis and septic shock – a significant independent risk factor for mortality: results from the German Prevalence Study. Nephrol Dial Transplant 2008;23:904–909.
32 Hoffmann JN, Hartl WH, Deppisch R, Faist E, Jochum M, Inthorn D: Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances. Kidney Int 1995;48:1563–1570.
33 Bellomo R, Kellum JA, Gandhi CR, Pinsky MR, Ondulik B: The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 2000;161:1429–1436.
34 Gomez H, Ince C, De Backer D, Pickkers P, Payen D, Hotchkiss J, et al: A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock 2014;41:3–11.
35 Ronco C, Kellum JA, Bellomo R, House AA: Potential interventions in sepsis-related acute kidney injury. Clin J Am Soc Nephrol 2008;3:531–544.
36 Oh HJ, Shin DH, Lee MJ, Koo HM, Doh FM, Kim HR, et al: Early initiation of continuous renal replacement therapy improves patient survival in severe progressive septic acute kidney injury. J Crit Care 2012;27:743.e9–e18.
37 Chon GR, Chang JW, Huh JW, Lim CM, Koh Y, Park SK, et al: A comparison of the time from sepsis to inception of continuous renal replacement therapy versus RIFLE criteria in patients with septic acute kidney injury. Shock 2012;38:30–36.
38 Carl DE, Grossman C, Behnke M, Sessler CN, Gehr TW: Effect of timing of dialysis on mortality in critically ill, septic patients with acute renal failure. Hemodial Int 2010;14:11–17.
39 Ostermann M, Dickie H, Barrett NA: Renal replacement therapy in critically ill patients with acute kidney injury – when to start. Nephrol Dial Transplant 2012;27:2242–2248.
40 Joannidis M, Forni LG: Clinical review: timing of renal replacement therapy. Crit Care 2011;15:223.
41 Karvellas CJ, Farhat MR, Sajjad I, Mogensen SS, Leung AA, Wald R, et al: A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care 2011;15:R72.
42 Shum HP, Chan KC: Timing for initiation of continuous renal replacement therapy in patients with septic shock and acute kidney injury. Ther Apher Dial 2013;17:643.
43 Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B, Boulet E, et al: Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 2016;375:122–133.